G-CSF in the Biology and Treatment of Acute Myeloid Leukemias

References

• Nicola N.A. Granulocyte colony-stimulating factor. Immunology Series 1990; 49: 77–109
   PubMedGoogle Scholar
• Metcalf D. The hemopoietic colony stimulating factors. Elsevier. 1984
   Google Scholar
• Tweardy D.J., Cannizzaro L.A., Palumbo A.P., Shane S., Heubner K., Vantuinen P., Ledbetter D.H., Finan J.B., Nowell P.C., Rovera G. Molecular cloning and characterization of acDNA for human granulocyte colony-stimulating factor (G-CSF) from a glioblastoma multiforme cell line and localization of the G-CSF gene to chromosome band 17q21. Oncogene Res. 1987; 1: 209–220
   PubMedGoogle Scholar
• Simmers R.N., Webber L.M., Shannon M.F., Garson O.M., Wong G., Vadas M.A., Sutherland G.R. Localization of G-CSF gene on chromosome 17 proximal to the breakpoint in the t(15;17) in acute promyelocytic leukemia. Blood 1987; 70: 330–332
   PubMed Web of Science ®Google Scholar
• Kanda N., Fukushige S.I., Murotsu T., Yoshida M.C., Tsuchiya M., Asano S., Kazior Y., Nagata S. Human gene coding for granulocyte colony-stimulating factor is assigned to the q21-q22 region of the chromosome 17. Somat. Cell. Mol. Cent. 1987; 13: 679–684
   PubMedGoogle Scholar
• Nicola N.A., Metcalf D. Binding of differentiation-inducer, granulocyte colony-stimulating factor, to responsive but not to unresponsive leukemic cell lines. Proc. Natl. Acad. Sci. 1984; 81: 3765–3769
   PubMed Web of Science ®Google Scholar
• Nicola N.A., Metcalf D. Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J. Cell. Fisiol. 1985; 124: 313–321
   Web of Science ®Google Scholar
• Nicola N.A., Begley C.G., Metcalf D. Identification of the human analogue of a regulator that induces differentiation in murine leukaemic cells. Nature 1985; 314: 626–628
   Web of Science ®Google Scholar
• Hara K., Suda T., Suda J., Ihle J.N., Nagataka S., Miura Y., Saito M. Bipotential murine cell line (NFS60) that is responsive to IL3, GM-CSF, G-CSF and erythropoietin. Exp. Hematol. 1988; 16: 256–261
   PubMed Web of Science ®Google Scholar
• Begley C.C., Metcalf D., Nicola N.A. Primary human myeloid leukemia cells: comparative responsiveness to proliferative stimulation by GM-CSF or G-CSF and membrane expression of CSF receptors. Leukemia 1987; 1: 1–8
   PubMed Web of Science ®Google Scholar
• Begley C.G., Metcalf D., Nicola N.A. Binding characteristics and proliferative action of purified granulocyte colony-stimulating factor (G-CSF) on normal and leukemic human promyelocytes. Exp. Hematol. 1988; 16: 71–79
   PubMed Web of Science ®Google Scholar
• Nicola N.A., Metcalf D. The colony-stimulating factors and myeloid leukemia. Cancer Sum. 1985; 4: 789–815
   PubMedGoogle Scholar
• Robinson B.E., Quesenberry P.J. Hematopoietic growth factors: overview and clinical applications. Parts I, II and III. Am. Med. Sci. 1990; 300: 163–170; 237–244, 311–321
   PubMed Web of Science ®Google Scholar
• Berdel W.E., Danhauser-Riedel R., Steinhauser R., Winton E.F. Various human hemopoietic growth factors (intcr-leukin-3, GM-CSF, G-CSF) stimulate clonal growth of non-hemopoietic tumor cells. Blood 1989; 73: 80–83
   PubMed Web of Science ®Google Scholar
• Delwel R., Salem M., Dorssers L., Wagemaker G., Clark S., Lowenberg B. Growth regulation of human acute myeloid leukemia: effects of five recombinant hemopoietic factors in serum-free culture system. Blood 1988; 72: 1944
   PubMed Web of Science ®Google Scholar
• Miyauchi J., Kelleher C.A., Yang Y.C., Wong G.C., Clark S.C., Minden M.D., Minkin S., McCulloch E.A. The effects of three recombinant growth factors, IL3, GM-CSF, and G-CSF on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood 1987; 70: 1987, 657
   Google Scholar
• Pebusque M.J., Pebusque M.J., Lopez M., Torres H., Carotti A., Guilbert L., Mannoni P. Growth response of human myeloid leukemia cells to colony-stimulating factors. Eq. Hematol. 1988; 16: 360
   Web of Science ®Google Scholar
• Vellenga E., Ostapovicz D., O'Rourke B., Griffin J.D. Effects of recombinant IL3, GM-CSF and G-CSF on the proliferation of leukemic clonogenic cells in short-term and long-term cultures. Leukemia 1987; 1: 584
   PubMed Web of Science ®Google Scholar
• Löwenberg B. Effects (of recombinant multi-CSF, GM-CSF, G-CSF and M-CSF on the proliferation and maturation of human AML in vitro. Blood Cells 1988; 14: 539–549
   PubMedGoogle Scholar
• Salem M., Delwel R., Mahmoud M.A., Clark S., Elbaz E.M., Lowenberg B. Maturation of human acute myeloid leukemia in vitro: the response to five recombinant haemopoietic growth factors in a serum-free system. Br. J. Hematol. 1989; 71: 363–369
   PubMed Web of Science ®Google Scholar
• Begley C.G., Metcalf D., Nicola N.A. Purified colony stimulating factors (G-CSF and GM-CSF) induce differentiation in human HL60 leukemic cells with suppression of clonogenicity. Int. J. Cancer 1987; 39: 99
   PubMed Web of Science ®Google Scholar
• Touw I., Donath J., Pouwels K., van Buitenen C., Schipper P., Santini V., Hagemeijer A., Delwel R. Acute myeloid leukemia with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukine 5. Leukemia 1991; 8: 687
   Google Scholar
• Huang F., Zhao H.P., Gao Z., Dai M.M., Fan L.L. Recombinant human G-CSF and retinoic acid synergistically induce granulocyte differentiation of human promyelocytic leukemic cells. Chin. Med. J. Engl. 1991; 105(9)707–12
   Web of Science ®Google Scholar
• Backx B., Broeders L., Rot F.J., Lowenberg B. Positive and negative effects of tumor necrosis factor on colony growth from highly purified normal marrow progenitors. Leukemia 1991; 5: 66–71
   PubMed Web of Science ®Google Scholar
• Salem M., Delwel R., Touw I., Mahmoud L.A., Elbaz E.M., Lowenberg B. Modulation of colony stimulating factor (CSF) dependent growth of acute myeloid leukemia by tumor necrosis factor. Leukemia 1990; 4: 37–43
   PubMed Web of Science ®Google Scholar
• Lowenberg B., Touw P. Hematopoietic growth factors and their receptors in acute leukemia. Blood 1993; 81: 281–292
   PubMed Web of Science ®Google Scholar
• Koeffler K., Gasson J., Ranyard G., Souza L., Shepard M., Munker R. Recombinant human TNFα stimulates production of granulocyte colony-stimulating factor. Blood 1987; 70: 55–61
   PubMed Web of Science ®Google Scholar
• Delwel R., van Buitenen C., Lowenberg B., Touw I.P. Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro. Blood 1992; 80: 1798–1803
   PubMed Web of Science ®Google Scholar
• Vellenga E., de Wolf J Th.M., Beentjes J.A.M., Esselink M.T., Smith J.W., Halie M.R. Divergent effects of inter-leukin-4 (IL4) on the granulocyte colony-stimulating factor and IL3 supported myeloid colony formation from normal and leukemic bone marrow cells. Blood 1990; 75: 633–39
   PubMed Web of Science ®Google Scholar
• Tessier N., Hoang T. Transforming growth factorβ inhibits the proliferation of the blast cells of acute myeloblastic leukemia. Blood 1988; 72: 155–65
   Google Scholar
• Nara N., Tohda S., Nagata K., Suziki T., Yamashita Y. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor beta. Leukemia 1989; 3: 572–77
   PubMed Web of Science ®Google Scholar
• Keller J.R., Jacobsen S.E., Dubois C.M., Hestdal K., Nuscetti F.W. Transforming growth factor beta: a bidirectional regulator of hemopoietic cell growth. Int. J. Cell. Cloning 1992; 10: 2–9
   PubMedGoogle Scholar
• Murohashi I., Tohda S., Suzuki T., Nagata K., Yamashita Y., Nara N. Autocrine growth mechanism of the progenitors of the blast cells in acute myeloblastic leukemia. Blood 1989; 74: 35–40
   PubMed Web of Science ®Google Scholar
• Delwel R., Schipper P., van Buitenen C., van Agthoven T., Touw I., Löwenberg B. Comparative analysis of IL1 regulated and spontaneous growth of acute myeloid leukemia in vitro. Bone Marrow Transplant. 1990; 6: 22
   PubMed Web of Science ®Google Scholar
• Bronchud M.H., Scarffe N., Thatcher D., Crowther L.M., Alton K., Testa N.G., Dexter T'.M. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br. J. Cancer 1987; 56: 805–816
   Web of Science ®Google Scholar
• Gabrilove J.L., Jakubowski A, Scher H., Stemberg C., Wong G., Grous J., Yagoda A., Fain K., Mooer M.A.S., Clarkson B., Oettge H.F., Alton K., Welte K., Sousa L. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N. Engl. J. Med. 1988; 318: 1414–1422
   PubMed Web of Science ®Google Scholar
• Crawford J., Ozer H., Stoller R., Johnson D., Lyman G., Tabbara I., Kris M., Grous J., Picozzi V., Rausch G., Smith R., Gradishar W., Yahanda A., Vincent M., Stewart M., Glaspy J. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small cell lung cancer. N. Engl. J. Med. 1991; 325: 164–170
   PubMed Web of Science ®Google Scholar
• Ogawa M., Masaoka T., Takaku F., Nakashima M. A phase III study of KRN 8601 (rhG-CSF) on neutropenia induced by chemotherapy for malignant lymphoma-a multiinstitutional placebo controlled double-blind comparative study. Gan to Kagaku Ryoho 1990; 17: 367–373
   Google Scholar
• Yoshida T., Nakamura S., Otake S., Okafuji K., Kubayashi K., et al. Effect of granulocyte colony-stimulating factor on neutropenia due to chemotherapy for non-Hodgkins lymphoma. Cancer 1990; 66: 1904–1909
   PubMed Web of Science ®Google Scholar
• Tafuri A., Andreeff H. Kinetic rationale for cytokine-induced recruitment of myeloblastic leukemia followed by cycle-specific chemotherapy in vitro. Leukemia 1990; 4: 826–834
   PubMed Web of Science ®Google Scholar
• Negrin R.S., Haeuber D.H., Nagler A., Kobayashi Y., Sklar J., Donlon T., Souza L.M., Greenberg P.L. Treatment of myelodysplastic syndromes with human granulocyte colony-stimulating factor. Exp. Hematol. 1988; 16: 519–26
   Web of Science ®Google Scholar
• Thompson J.A., Lee D.J., Kidd P., Rubin E., Kaufmann J., Bonnem E., Fefer A. Subcutaneous granulocyte colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics and hematological effects. J. Clin. Oncol. 1989; 7: 629–35
   PubMed Web of Science ®Google Scholar
• Ohno R., Tomanoga M., Kobayashi T., Kanamaru A., Shirakawa S., Masaoka T., Omine M., Oh H., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A.B., Morishima Y., Dohy H., Niho Y., Hamajima N., Takaku F. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory leukemia. N. Engl. J. Med. 1990; 871–877
   PubMed Web of Science ®Google Scholar
• Takauji R., Tohyama K., Ueda T., Nakamura T. Enhancement of cytosine arabinoside cytotoxicity by granulocyte/macrophage colony-stimulating factor and granulocyte colony-stimulating factor in a human myeloblastic leukemia cell line. Jpn. J. Cancer Res. 1993; 84: 445450
   Google Scholar
• Gandhi V., Estey E., Plunkett W. Biological modulation of nucleoside analog metabolism by granulocyte colony-stimulating factor during therapy. Blood 1993; 82: 354, Suppl. 1
   Google Scholar
• Tosi P., Visani G., Ottaviani E. Fludarabine + ARA-C + G-CSF: Cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells. Leukemia 1994, in press
   Web of Science ®Google Scholar
• Ohno R., Naoe T., Kanamaru A., Yoshida M., Hiraoka A., Kobayashi T., Ueda T., Minami S., Moroshima Y., Saito Y., Furusawa S., Imai K., Takemoto Y., Miura Y., Teshima H., Hamajima N. Konseisho Leukemia Stoudy Group., A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood 1994; 83: 2086–93
   PubMed Web of Science ®Google Scholar
• Estey E., Thall P., Andreef M., Kantarjian H., O'Brien S., Escudier S., Robertson L.E., Koller C., Komblau S., Pierce S., Freireich E.J., Deisseroth A., Keating M. Use of G-CSF before, during and after fludarabine + ara-C induction therapy of newly diagnosed AML or MDS: comparison with fludarabine + ara-C without G-CSF. J. Clin. Oncol. 1994; 12: 671–678
   PubMed Web of Science ®Google Scholar
• Ishikawa J., Yoshimura M., Matsunashi T., Tominaga N., Teshima H., Hiraoka A., Nakamura H., Shibata H., Masaoka T., Takaku F. Clinical effect of granulocyte colony-stimulating factor on neutrophils and leukemic cells in myelogenous leukemia. Jpn. J. Clin. Oncol. 1991; 21: 169–175
   PubMed Web of Science ®Google Scholar
• Morstyn G., Souza L.M., Keech J., Campbell L., Alton N.K., Green M., Sheridan W., Metcalf D., Fox R. Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988; 1: 667–672
   PubMed Web of Science ®Google Scholar
• Teshima H., Ishikawa J., Kitayama H., et al. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study. Exp. Hematol. 1989; 17: 853–858
   PubMed Web of Science ®Google Scholar
• Bodey G.P., Buckley M., Sathe Y.S., Freireich E.J. Quantitative relationship between circulating leukocytes and infections in patients with acute leukemia. Ann. Inf. Med. 1966; 64: 238–240
   Google Scholar
• Estey H. Use of colony-stimulating factors in the treatment of acute myeloid leukemia. Blood 1994; 83: 2015–2019
   PubMed Web of Science ®Google Scholar
• Gulati S.C. Did we focus on the most important issues in the use of growth factors and stem-cell transplantation?. J. Clin. Onc. 1994; 12: 650–652
   PubMed Web of Science ®Google Scholar
• Sheridan W.P., Begley C.G., Juttner C.A., Szer J., To L.B., Maher D., McGrath K.M., Morstyn G., Fox R.M. Effect of peripheral blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640–644
   PubMed Web of Science ®Google Scholar
• Sheridan W.P., Morstyn G., Wolf M., Dodds A., Lusk J. Granulocyte colony stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891–894
   PubMed Web of Science ®Google Scholar
• Peters W.P., Kurtzburg J., Atwater S. Comparative effect of r-HUG-CSF and r-HuGM-CSF on hemopoietic reconstitution and granulocyte function following high-dose chemotherapy and autologous bone marrow transplantation (ABMT). Proceedings of the American Society of Clinical Oncology 1989; 8: 702A
   Google Scholar
• Peters W.P. The effect of recombinant human colony stimulating factors on hemopoietic reconstitution following autologous bone marrow transplantation. Sem. Hematol. 1989; 26: 18–23, 2 Suppl. 2
   PubMed Web of Science ®Google Scholar
• Gisselbrecht C., Prentice G., Bacigalupo A., Biron P., Milpied N., Rubie H., Cunningham D., Legros M., Pico J.L., Linch D.C., Burnett A.K., Scarffe J.H., Siegert W., Yver A. A phase III randomized placebo-controled study in 315 pediatric and adult autologous or allogeneic bone marrow transplantation with lenograstim 5μg/Kg/day (glicosilated rHu-G-CSF). Blood 1993; 82: 445a, suppl. 1
   Google Scholar
• Schriber J.R., Nelson J.C., Gwynn D.L., Negrin R.S., Blume K.G. Granulocyte colony-stimulating factor (G-CSF) following allogeneic bone marrow transplantation. Blood 1993; 82: 286a, suppl. 1
   Google Scholar
• Schwartzberg L., Birch R., Heffernan M., West W. G-CSF is an effective supportive modality in peripheral blood stem cell (PBSC) transplantation. Blood 1993; 82: 286a, suppl. 1
   Google Scholar
• Vredenburg J.J., Waters-Pick B., Kurtzberg J., Drago S., Ross M., Hussein A., Peters W.P. A single 6-hour (HR) steady state leukapheresis is sufficient for collection of peripheral blood progenitor cells (PBSC) after G-CSF. Blood 1993; 82: 349a, suppl. 1.
   Google Scholar